rkausar
- 12 Aug 2004 10:43
Shares mag. recommending this stock this week. Is this going to be our killer this christmas!!!! any comments anyone?????
zscrooge
- 08 Dec 2006 20:32
- 175 of 297
LOL!
Price is same as the start of 2002.
Give me some of that new drug.
myway
- 11 Dec 2006 09:22
- 176 of 297
The Directors must be in the know.. As they have been buying shares as if they are going out of fashion.!!
I understand that the results from CeNeS pivotal Phase III trial are expected in early 2007, then and only then will the market know the true information and value on the product/company. With 4.28m from the pacing of new shares the company will be able to further strengthen its balance sheet ahead of any announcement
johnny the fox
- 12 Dec 2006 17:21
- 177 of 297
Some big buys today. Trading has certainly perked up of late so something is afoot.
Good news expected soon maybe?
Certain the wait will be well worth it long term.
capetown
- 13 Dec 2006 12:14
- 178 of 297
SMALL ARTICLE IN FT.
GLAXO rumor lifts cenes.????????
ARE WE READY FOR TAKEOFF?
johnny the fox
- 13 Dec 2006 18:12
- 179 of 297
Capetown
Could you e me the article? I know you will infringe copywrite if you paste it here.
Cheers
johnny the fox
- 13 Dec 2006 18:14
- 180 of 297
Whoops!
capetown
- 13 Dec 2006 18:18
- 181 of 297
JOHNNY you have mail
johnny the fox
- 13 Dec 2006 21:12
- 182 of 297
capetown
Hi, Thanks for that. I must confess to being a little dubious about rumours even when they appear in the FT but if Glaxo is showing interest ..... who knows?
The sp is starting to look a lot healthier. Lets hope for good news in January
Cheers
parthus
- 14 Dec 2006 20:40
- 183 of 297
i'm a little behind the game on this one, but happy to be back in since exit in late january. a little short profit from idd. out of the frying pan into the fire??!!
Jobibear
- 15 Dec 2006 13:37
- 184 of 297
Just topped up.
Jobibear
- 19 Dec 2006 22:38
- 185 of 297
I, although in moments constantly unsure (and more constantly wrong), believe today's slight move up to be a good indicator of CENES. Previous downward movement in the FT100 index has indefinitely meant a downward movement in CENES price (despite changes with CENE's own market value). However today's FT100 dip of 0.7% (46.5pts) was bettered by CENES who went up by 3.28% (0.25pts). Although aware of some the dynamics of market price and some associated ideas, I believe CENES up spike marks a recent and significant anomoly. However DYOR.
parthus
- 20 Dec 2006 00:23
- 186 of 297
have you been drinking jobi?
Jobibear
- 21 Dec 2006 09:14
- 187 of 297
I was, and I shall be tonight. Seasonal Greetings one and all. & CENES post those results and put me out of my misery.
parthus
- 21 Dec 2006 09:52
- 188 of 297
And to you Jobi. Have a good night.I'm sure CEN will buy you a drink!
johnny the fox
- 03 Jan 2007 14:43
- 189 of 297
Onward & upwards.
Although this time last year the sp headed north & fell back. If we have some good news as expected this month, we should see some exceptional gains this year.
Best wishes to & good luck to one & all for '07.
andysmith
- 24 Jan 2007 07:45
- 190 of 297
Added some more yesterday. Hopefully news soon.
Ludlow Castle
- 24 Jan 2007 09:35
- 191 of 297
CEN could blow any day now.
M6G results probably within 4 weeks imo.
Ludlow Castle
- 24 Jan 2007 10:15
- 192 of 297
Objective Capital gave CeNeS a Fair Value of 27p last month:
http://www.proactiveinvestors.co.uk/registered/research/objective-cenes-dec06.pdf
queen1
- 24 Jan 2007 12:15
- 193 of 297
Bless them!
queen1
- 26 Jan 2007 08:38
- 194 of 297
CEN said it could receive up to 5 mln usd in milestone payments over the next few years if trials of its experimental smoking cessation drug, being carried out by a licensee, prove successful.
The group out licensed the selective dopamine D1 receptor antagonist, called ADX10061, to Addex Pharmaceuticals in 2002. The group has now started a phase IIa study in the US, and positive results will trigger the payments to CEN.
The company would also receive annual royalties on sales, should ADX10061 reach the market.
'Whilst we are not guaranteed success from any of our carried interests the chance of realising a financial return from Addex is much increased as a result of them commencing this phase II trial,' CEN chief executive Neil Clark said in a statement.